Connect with us

Health

COVID-19 Vaccine News: Moderna Variant Vaccine Begins Human Testing, AZ Put on Hold in Denmark – BioSpace

Patients in a Phase II trial have begun receiving Moderna’s vaccine against the SARS-CoV-2 variant first identified in South Africa, the company announced.

Published

on

Article feature image

Patients in a Phase II trial have begun receiving Modernas vaccine against the SARS-CoV-2 variant first identified in South Africa, the company announced. The modified vaccine, mRNA-1273.351, is being tested out of an abundance of caution, despite the fact that previous data has shown that the companys marketed mRNA-1273 vaccine produces neutralizing titers against all relevant variations, the company said.
Similarly inspired by caution, Denmark announced it is temporarilystopping vaccinations with…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending